The surge in insider buying at OPKO Health, Inc. (NASDAQ:OPK) is picking up steam with the current sell/buy ratio now at 0. OPK recorded 0 sales on the open market in the last three months. They sold nearly zero shares while purchases amounted to 90,000 shares that period. Looking even further back to 12 months, corporate insiders offloaded 108,946 shares when buyers snapped up 4,057,944 shares. The 12-month’s totals signify about a 0.03-to-1 sell/buy ratio.
Fishel Robert Scott gathered a total of 10 thousand shares of OPKO Health, Inc. (OPK) at average share price of $4.63. This insider trade in the company took place on 09/07/2018. The total for the purchase was set at $46.3 thousand. After this transaction, the Director account balance stood at 4.07 million shares. The stock lost -16.63 percent since that insider purchase. On 09/07/2018, Frost Phillip Md Et Al, CEO & Chairman, 10% Owner, purchased 10 thousand shares at a price per share of $5.57. This added 55.7 thousand shares to the insider’s fortune and the stock saw a -30.7 percent retreat in value since the news became public. This transaction left 192 million shares in the CEO & Chairman, 10% Owner account.
On 09/05/2018, CEO & Chairman, 10% Owner Frost Phillip Md Et Al performed a purchase transaction worth $57.9 thousand. This purchase at $5.79 each has added 10 thousand shares into the insider’s portfolio position. Meanwhile, shares have recorded -33.33 percent decrease since the transaction was reported. The insider now is left with 192 million shares remaining in the account. Frost Phillip Md Et Al, who performs the CEO & Chairman, 10% Owner job, bought 5 thousand shares for $29.5 thousand. The acquisition occurred on 08/30/2018 was priced at $5.9 per share. The share price plunged -34.58 percent since the reporting date. Frost Phillip Md Et Al now left with a stake of 192 million OPK stock worth $741.12 million after the insider buying.
The 12-month median price target for OPKO Health, Inc. (OPK) assigned by the analysts stands at $13, which represents a return potential of 236.79 percent when compared to the closing price of the stock of $3.86 on Wednesday, November 07. The lowest price target for the stock is $4.5 — slightly more than 16.58 percent from OPK’s current share price. The stock will probably climb 227.2 percent over the next 12 months, according to price target estimates compiled by finviz. Meanwhile, they have set a $20-month high price target. This represents a whopping 418.13 percent increase from where shares are trading today.
On momentum oscillators front, ‘RSI’ has touched 50.27 on daily chart, which may remain a cause for concern. If the price breaks below $3.61 level on closing basis, then we may see more profit booking and the stock may show further weakness. On the flipside, hitting the $3.95 mark may result into a pull-back move towards $4.04 level. The stock is currently hovering around the first support level of $3.74. Below this, the next support is placed in the zone of $3.61. Till the time, the OPK stock trades above this level, bulls have nothing to fear.
Shares of OPKO Health, Inc. (OPK) are trading at a P/E ratio of 0 times earnings reported for the past 12 months. The industry OPK operates in has an average P/E of 26.82. Its P/E ratio went as low as 0X and as high as 0 over the 5-year span. Further, it is sporting a 2.15 on the Price-to-Sales ratio. Compare this with the industry average P/S of 13.01. 37.3 percent is the gross profit margin for OPKO Health, Inc. and operating margin sits at -26.6 percent. Along with this, the net profit margin is -31.7 percent.
On 7th of November, OPKO Health, Inc. (NASDAQ:OPK) shares ended higher after a volatile session. The shares accumulated 0.14 points or 3.76 percent at $3.86 with a light trade volume of 3.756 million shares. After opening the session at $3.72, the shares went as high as $3.92 and as low as $3.705, the range within which the stock’s price traded throughout the day. The firm is left with a market cap of $2.1 billion and now has 543.45 million shares outstanding. OPKO Health, Inc. (OPK) stock has gained 11.24 percent of market value in 21 trading days.
In last reported earnings results, OPK earned -$0.01 per share, better than the -$0.07, adjusted, expected by Thomson Reuters consensus estimate. Revenue was $264M, better than the $262M analysts expected. Earnings are estimated to increase by 51 percent this year, 8.3 percent next year and continue to increase by 12 percent annually for the next 5 years. Analysts are forecasting revenue to climb 0.2 percent to $264M in the next fiscal quarter, while earnings are seen soaring by nearly 0 percent to -$0.08 per share. History has shown that shares in OPKO Health, Inc. have gone down on 17 different earnings reaction days and are predicted to add 0.04 percent when the company reports upcoming earnings.
OPK stock has a trailing 3-year beta of 1.89, offering the possibility of a higher rate of return, but also posing more risk. The portion of a company’s profit allocated to each outstanding share of common stock was -$0.55 a share in the trailing twelve months. The stock’s value has fallen -21.22 percent year to date (YTD) against a decline of -40.8 percent in 12 month’s time. The company’s shares still trade -42.47 percent away from its 1-year high of $6.71 and 45.11 percent up from 52-week low of $2.66. The average consensus rating on the company is 2.4, on a scale where 5 equates to a unanimous sell rating. In short, the mean analyst recommendations are calling this stock a sell.